Australia, Nov. 25 -- CSL Behring Gene Therapy Inc., owns the trademark (2457763) for 'CYTEGRITY' till Feb. 14, 2034.
Status: protected:
Registered/protected
Classes: 40 [Biomanufacturing for others, namely, manufacturing of pharmaceuticals and of viral vectors and gene therapy vectors; custom manufacturing services of ex vivo, lentiviral stable cell lines; custom manufacturing services of lentiviral vectors by transient transfection; biomanufacturing of viral vectors and gene therapy vectors; biomanufacturing services of cell lines and cells; biomanufacturing of biological preparations.], 42 [Scientific, pharmaceutical and medical research and development; biological research; laboratory services in connection with viral vectors and gene...